Earlier studies provided suggestive evidence about the effectiveness of pas
sive immunotherapy for AIDS patients using plasma donated by healthy HIV-1
infected individuals and revealed beneficial effects of plasmapheresis for
the immune system of the donors. In this study, anti-HIV-1 neutralizing act
ivity in 31 healthy HIV-1 infected donors of plasma participating in a pass
ive immunotherapy study was investigated as a function of time. Average stu
died period was 33 months. Using the highly cytopathic HIV-1 NDK strain and
MOLT4 cells, it was shown by means of syncytia formation inhibition assay
and polyclonal HIV-1 antigen-capture assay that viral neutralizing titers t
end either to remain unchanged or increase over time. These findings suppor
t the notion that the immune system is not affected adversely in HIV-1 infe
cted plasma donors and lend further support to the feasibility of passive i
mmunotherapy for AIDS patients. (C) 2001 Wiley-Liss,Inc.